You are here

Neurothrombectomy: Improving Stroke Outcomes

The results of the latest studies utilizing advanced brain imaging technology are changing the stroke treatment guidelines. The DEFUSE 3 study expands on the results of the MR CLEAN and DAWN studies, and allow for extended window for thrombectomies to as long as 24 hours in some cases. It also broadens the population eligible for clot-busting medication to people with mild strokes.

Neurothrombectomy: Improving Stroke Outcomes is an expanded education initiative comprising of three webinars that focus on the latest research results and improving stroke outcomes

 

Find a Support Group

Go

Get Involved

 

For over 30 years we have been the trusted source for free resources and education to the stroke community. Together, we empower survivors and their circle of care to thrive after stroke. Make your tax-deductible donation today to support the growing needs of the stroke community.